Phase
Condition
Infertility
In Vitro Fertilization
Treatment
Cervical mucus will be collected from patients undergoing IVF
Cervical mucus will be collected from patients undergoing transfer of cryopreserved embryos
Clinical Study ID
Ages < 36 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria - Arm A - stimulated cycle:
female aged less than 37 years (maximally 36y + 364d)
no smoker
normal menstrual cycles lasting between 25 to 35 days
had been infertile for less than five years
normal responder
fewer than three failed cycles of assisted reproduction treatment, including fresh IVF/ intracytoplasmic sperm injection (ICSI) embryo transfer cycles and/or frozen-thawed embryo transfer cycles
sperm obtained through ejaculation
spermiogram more than 5 million sperm/mL
BMI 19-29 kg/m2
follicle stimulating hormone (FSH) < 10 IU/L on the third day
basal antral follicle count of 5-15
undergoing the same routine gonadotrophin-releasing hormone agonist (GnRHa) long depot or gonadotrophin-releasing hormone antagonist (GnRH-ant.) protocol
informed consent
Exclusion Criteria - Arm A - stimulated cycle:
genetic disease
metabolic and/or endocrine disorders
polycystic ovary syndrome (defined by the Rotterdam criteria)
women with prior diagnosis of endometriosis or adenomyosis
previous gynecological/pelvic surgery except for salpingectomy
repeated spontaneous abortions (two or more)
previously less than 5 oocytes and/or serum anti-Mullerian hormone value < 1.0 mIU/ml or more than 20 oocytes, milli-International unit (mIU)
previous ovarian hyperstimulation syndrome (OHSS)
presence of any structural abnormality of the reproductive system
donor oocyte cycles
severe male factor infertility < 5 million sperm/mL
low response to stimulation
endometrium < 8 mm at the day of human chorionic gonadotropin (hCG) or ET
number of retrieved oocytes 5 - 20
low fertilization capacity (rate of fertilization < 20% and late ICSI following IVF fertilization failure)
OHSS
IVF cycle cancelled before ET
other than easy one high-quality blastocyst transfer (at least grade 3BB)
Inclusion criteria - Arm B - substituted cycle:
female aged less than 37 years (maximally 36y + 364d)
no smoker
normal menstrual cycles lasting between 25 to 35 days
had been infertile for less than five years
normal responder at stimulation
fewer than three failed cycles of assisted reproduction treatment, including fresh IVF/ intracytoplasmic sperm injection (ICSI) embryo transfer cycles and/or frozen-thawed embryo transfer cycles
sperm obtained through ejaculation
spermiogram more than 5 million sperm/mL
BMI 19-29 kg/m2
FSH < 10 IU/L on the third day
undergoing the same routine estrogen/progesterone substituted cycle
informed consent
Exclusion criteria - Arm B - substituted cycle:
genetic disease
metabolic and/or endocrine disorders such as diabetes, metabolic syndrome, and thyroid disorders
polycystic ovary syndrome (defined by the Rotterdam criteria), hyperprolactinaemia
women with prior diagnosis of endometriosis or adenomyosis
previous gynecological/pelvic surgery except for salpingectomy
repeated spontaneous abortions (two or more)
previously less than 5 oocytes and/or serum anti-Mullerian hormone value < 0.5 mIU/ml in the stimulated cycle
previous OHSS
presence of any structural abnormality of the reproductive system
severe male factor infertility < 5 million sperm/mL in the stimulated cycle
number of retrieved oocytes 5 - 20 in the stimulated cycle
low fertilization capacity (rate of fertilization < 20% and late ICSI following IVF fertilization failure)
endometrium less than 8 mm at the day of thawing and transfer indication
thawed blastocyst cycle cancelled before ET
other than easy one best quality frozen/thawed blastocyst transfer (at least grade 3BB)
Study Design
Study Description
Connect with a study center
Brno University Hospital
Brno, Jihomoravsky Kraj 62500
CzechiaActive - Recruiting
University Hospital Olomouc
Olomouc, 77900
CzechiaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.